The "null effect" of low-density lipoprotein cholesterol lowering on a modest baseline intima-media thickness: lessons learned from the ENHANCE trial.
Franklin
Barry A
BA
Department of Medicine, Division of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA. bfranklin@beaumont.edu
McCullough
Peter A
PA
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D017536:Carotid Artery, Common / Q000000981:diagnostic imaging*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D017539:Tunica Intima / Q000000981:diagnostic imaging; D014463:Ultrasonography
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL